Addus HomeCare Corporation

NASDAQ:ADUS

Medical - Care Facilities

Healthcare
$120.85 +0.31%

+$0.29 today

Market cap
$2.25B
Beta
0.90
P/E (TTM)
17.4
EPS (TTM)
$5.40
52W Low $87.95High $124.44

Volume 0.23M

Average 0.25M

ADUS Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Addus HomeCare CorporationNASDAQ: ADUS

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue grows, but more slowly than its trailing trend

Q2 FY2026 cost of revenue of $255.86M rose 8.6% year over year, behind the +16.3% change in trailing-twelve-month cost of revenue. Sequentially, it rose 3.3% from the prior quarter. Over 3 fiscal years it compounded at +13.8% a year.

Context

  • Cost of revenue amounted to 67.5% of revenue in FY2025, unchanged from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +8.6% toward the trailing-twelve-month pace of +16.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$255.86M+3.3% QoQ
Last fiscal yearDec 2025
$960.66M+23.2% YoY
LTMJun 2026
$998.65M+16.3% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.6%——
1 year+23.2%——
3-year CAGR+13.8%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
960.66M USD
Year-over-year change
+23.2%
4-year CAGR
+12.7%

Cost of Revenue vs competitors

How ADUS compares with its peers on the latest reported figures

  • ADUS's LTM Jun 2026 cost of revenue of $998.65M is the 6th highest of the 7 companies compared; the peer median is $1.81B.
  • Its year-over-year change of +16.3% is the 5th highest of 7, against a peer median of +18.1%.
  • Cost of revenue amounts to 67.6% of revenue for ADUS, versus a peer median of 68.8%.
ADUS Competitors Peer median
Cost of Revenue for ADUS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ENSGThe Ensign Group, Inc.LTM Jun 2026$4.71B +21.3%+19.3%85.9%
EHCEncompass Health CorporationLTM Jun 2026$3.48B +6.6%+9.1%56.1%
AVAHAveanna Healthcare Holdings Inc.LTM Oct 2026$1.82B +19.3%+9.7%67.9%
CHEChemed CorporationLTM Jun 2026$1.81B +8.3%+9.0%69.6%
NHCNational HealthCare CorporationLTM Sep 2026$1.08B +16.9%+10.3%68.0%
ADUSAddus HomeCare CorporationLTM Jun 2026$998.65M +16.3%+13.8%67.6%
PNTGThe Pennant Group, Inc.LTM Mar 2026$871.95M +35.1%+25.8%85.2%
Peer median (excluding ADUS) $1.81B+18.1%+10.0%68.8%

Competitors are the stored peer set for ADUS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue864.5M951.12M1.06B1.15B1.42B
Cost of Revenue595.24M651.38M718.78M779.58M960.66M
Gross Profit269.85M299.74M339.88M375.02M461.87M
Gross Margin31.2%31.5%32.1%32.5%32.5%
Research & Development00000
Selling, General & Admin189.42M216.94M231.68M258.8M306.85M
Operating Expenses203.32M231M248.92M272.33M323.26M
Depreciation & Amortization14.49M14.06M14.13M13.53M16.41M
EBITDA80.7M83.14M106.56M120.62M153.44M
EBITDA Margin9.3%8.7%10.1%10.4%10.8%
Operating Income65.94M68.74M90.96M102.69M138.62M
Operating Margin7.6%7.2%8.6%8.9%9.7%
Interest Income268K341K1.48M4.39M1.59M
Interest Expense5.81M8.91M11.11M7.73M9.58M
Other Income / Expenses(5.54M)(8.57M)(9.63M)(3.34M)(11.17M)
Income Before Tax60.4M60.17M81.33M99.35M127.45M
Pre-Tax Margin7.0%6.3%7.7%8.6%9.0%
Income Tax Expense15.27M14.15M18.81M25.76M31.54M
Net Income45.13M46.03M62.52M73.6M95.91M
Net Margin5.2%4.8%5.9%6.4%6.7%
EPS (Basic)2.872.903.914.335.19
EPS (Diluted)2.812.843.834.235.21
Weighted Avg Shares15.74M16.13M16.23M17.01M18.45M
Weighted Avg Shares (Diluted)16.06M16.18M16.31M17.38M18.45M

Addus HomeCare Corporation

NASDAQ:ADUS

Intrinsic Alpha fair value

Locked

Current Price

$120.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.